Connor, Clark & Lunn Investment Management (CC&L)’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
|
|||||
|
2025
Q1 | $14.3M | Sell |
|
|||||
|
2024
Q4 | $19.7M | Buy |
|
|||||
|
2024
Q3 | $17.7M | Buy |
|
|||||
|
2024
Q2 | $3.38M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.53M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $341K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $266K | Buy |
|
|||||
|
2017
Q2 | $206K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $290K | Sell |
|
|||||
|
2016
Q1 | $396K | Sell |
|
|||||
|
2015
Q4 | $459K | Sell |
|
|||||
|
2015
Q3 | $898K | Buy |
|